Your browser doesn't support javascript.
loading
Safety and immunogenicity of locally produced trivalent inactivated influenza vaccine (Tri Fluvac) in healthy Thai adults aged 18-64 years in Nakhon Phanom: A Phase III double blinded, three-arm, randomized, controlled trial.
Prasert, Kriengkrai; Praphasiri, Prabda; Lerdsamran, Hatairat; Nakphook, Sutthichai; Ditsungnoen, Darunee; Chawalchitiporn, Sutthinan; Sornwong, Kanlaya; Poopipatpol, Kittisak; Wirachwong, Ponthip; Narakorn, Piengthong; Surichan, Somchaiya; Suthepakul, Nava; Thangsupanimitchai, Napawan; Pittayawonganon, Chakrarat; Puthavathana, Pilaipan; Davis, William W; Mott, Joshua A; Olsen, Sonja J; Patumanond, Jayanton.
Affiliation
  • Prasert K; Nakhon Phanom Provincial Hospital, Nakhon Phanom, Thailand; Faculty of Public Health, Kasetsart University, Chalermprakiat Sakon Nakhon Province Campus, Thailand.
  • Praphasiri P; Faculty of Public Health, Kasetsart University, Chalermprakiat Sakon Nakhon Province Campus, Thailand; Influenza Program, Thailand Ministry of Public Health-U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand. Electronic address: hpu3@cdc.gov.
  • Lerdsamran H; Center for Research and Innovation, Faculty of Medical Technology, Mahidol University, Salaya, Nakhon Pathom, Thailand.
  • Nakphook S; Faculty of Public Health, Kasetsart University, Chalermprakiat Sakon Nakhon Province Campus, Thailand; Institute of Preventive Medicine, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand.
  • Ditsungnoen D; Influenza Program, Thailand Ministry of Public Health-U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.
  • Chawalchitiporn S; Nakhon Phanom Provincial Hospital, Nakhon Phanom, Thailand.
  • Sornwong K; Nakhon Phanom Provincial Hospital, Nakhon Phanom, Thailand.
  • Poopipatpol K; Government Pharmaceutical Organization (GPO), Bangkok, Thailand.
  • Wirachwong P; Government Pharmaceutical Organization (GPO), Bangkok, Thailand.
  • Narakorn P; Government Pharmaceutical Organization (GPO), Bangkok, Thailand.
  • Surichan S; Government Pharmaceutical Organization (GPO), Bangkok, Thailand.
  • Suthepakul N; Government Pharmaceutical Organization (GPO), Bangkok, Thailand.
  • Thangsupanimitchai N; Government Pharmaceutical Organization (GPO), Bangkok, Thailand.
  • Pittayawonganon C; Institute of Preventive Medicine, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand.
  • Puthavathana P; Influenza Program, Thailand Ministry of Public Health-U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.
  • Davis WW; Influenza Program, Thailand Ministry of Public Health-U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Mott JA; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Olsen SJ; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Patumanond J; Clinical Epidemiology Unit, Faculty of Medicine, Chiang Mai University, Thailand.
Vaccine ; 42(1): 24-32, 2024 Jan 01.
Article de En | MEDLINE | ID: mdl-38042698
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins antigrippaux / Grippe humaine / Sous-type H1N1 du virus de la grippe A Limites: Adult / Humans Pays/Région comme sujet: Asia Langue: En Journal: Vaccine Année: 2024 Type de document: Article Pays d'affiliation: Thaïlande
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins antigrippaux / Grippe humaine / Sous-type H1N1 du virus de la grippe A Limites: Adult / Humans Pays/Région comme sujet: Asia Langue: En Journal: Vaccine Année: 2024 Type de document: Article Pays d'affiliation: Thaïlande